Nasal Drug Delivery Technology Market (By Dosage Form: Spray, Drops, Gel, Powder; By Container Type: Pressurized, Non-pressurized; By Therapeutic Application: Nasal Congestion, Rhinitis, Asthma, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Published at : January-2019 | Delivery Format : PDF | Status: Published | Pages : 160


The global nasal drug delivery technology market size is expected to around USD 68.1 billion by 2026, this market is foreseen to develop with 7.3% CAGR during the forecast time period.

Market Dynamics

Rising mindfulness about nasal products is one of the central point driving the market. Developing geriatric populace is likewise expected to have positive effect available. As per the United Nations Department of Economic and Social Affairs, the worldwide geriatric populace (60 years or more), was around 962 million out of 2017. The number is relied upon to develop, especially in Latin America with 71% ascent in populace matured 60 and over, trailed by Asia (66%), Africa (64%), North America (41%), and Europe (23%).

Expanding inclination for elective method of medication organization is one of the main considerations expected to fuel the market development amid the estimate time frame. Developing frequency of chronic diseases is likewise expected to add to the market extension over the coming years.

Market Insights

Based on container type, the nasal drug delivery systems market is into pressurized and non-pressurized containers. Non-pressurized was the biggest container type segment in 2018. These container are generally found in nasal sprays, powders, and gels. Developing demand for related items is required to move the segment over the coming years. Besides, as indicated by an article distributed by Intertek Group PLC, nasal medication conveyance advancements empower systematically or topical medication conveyance.

Every one of these components are required to help the portion development. Pressurized compartment type is assessed to be the quickest developing fragment at a CAGR of 7.7% over the estimate time frame. These holders are for the most part found in nasal splashes. Popularity for nasal splashes because of expanding pervasiveness of endless sickness, for example, asthma, diabetes, and Cardiovascular Diseases (CVDs) is foreseen to drive the section development.

Market Segmentation

Market By Dosage Form

  • Spray
  • Drops
  • Gel
  • Powder

Market By Container Type

  • Pressurized
  • Non-pressurized

Market By Therapeutic Application

  • Nasal Congestion
  • Rhinitis
  • Asthma
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America drove the market with an income offer of 36.41% in 2018. This development was ascribed to expanded malady pervasiveness combined with purchaser mindfulness about nasal products. As per CDC, in 2017, the quantity of grown-ups with asthma matured 18 years or more in U.S. were around 20.4 million contributing roughly 8.3% of the all-out populace in the nation. In addition, the quantity of kids under 18 years old with asthma was around 6.1 million. North America will observer stronger development throughout the following couple of years because of created economies in the region.

Asia Pacific is relied upon to witness the quickest CAGR of 7.5% in the coming years. This development is for the most part because of accessibility of viable treatment strategies, high neglected clinical requirements, rising disposable income, and expanding mindfulness about these products. Also, the nearness of key organizations in this region, for example, AptarGroup, Inc.; Sun Pharmaceutical Industries Ltd.; and Cipla Inc., is required to positively affect the general market.

Market Participants

Few of the main player present in the global Nasal drug delivery technology market are NAVEH Pharma Ltd.; GlaxoSmithKline PLC; ENT Technologies Pty. Ltd.; AstraZeneca PLC; Douglas Pharmaceuticals Ltd.; Pfizer, Inc.; PendoPharm, Inc.; OptiNose, Inc.; B.F. Ascher& Company, Inc.; Becton, Dickinson and Company; Cadila Pharmaceuticals Ltd.; and Promius Pharma, LLC.

Cart Summary